Exact Sciences Corp
NASDAQ:EXAS

Watchlist Manager
Exact Sciences Corp Logo
Exact Sciences Corp
NASDAQ:EXAS
Watchlist
Price: 50.88 USD 0.3% Market Closed
Market Cap: 9.4B USD
Have any thoughts about
Exact Sciences Corp?
Write Note

Exact Sciences Corp
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Exact Sciences Corp
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Exact Sciences Corp
NASDAQ:EXAS
Gross Profit
$2B
CAGR 3-Years
14%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$37.3B
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
9%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$22B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.7B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$9.2B
CAGR 3-Years
13%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$12B
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
17%

See Also

What is Exact Sciences Corp's Gross Profit?
Gross Profit
2B USD

Based on the financial report for Sep 30, 2024, Exact Sciences Corp's Gross Profit amounts to 2B USD.

What is Exact Sciences Corp's Gross Profit growth rate?
Gross Profit CAGR 5Y
29%

Over the last year, the Gross Profit growth was 11%. The average annual Gross Profit growth rates for Exact Sciences Corp have been 14% over the past three years , 29% over the past five years .

Back to Top